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A year ago, in this journal, Zhang and coworkers
(Zhang et al., 2005) reported that the gene encoding
the enzyme responsible for the synthesis of brain sero-
tonin, tryptophan hydroxylase-2 (THP2), exhibited a
functional variant associated with major (or unipolar)
depression. The variant in question (G1463A) altered a
critical amino acid (Arg441His) in the enzyme such
that, at least in a transfected cell model, serotonin syn-
thetic capacity was significantly attenuated. Even more
striking, the frequency of the variant was increased in
a cohort of depressed subjects, reinforcing a common
suspicion that the availability of or response to seroto-
nin is altered in depression. Although serotonin has
been studied in the brain for decades, only in the past
few years has the central role of TPH2 become clear.
Like the sighting of a long-suspected but as yet un-
charted island, the discovery of functional variation in
human TPH2 associated with depression was heralded
as a major opportunity to move from correlation to cau-
sality and anchor a flag for the serotonin hypothesis of
depression on terra firma.
But the party was short lived. As noted by the letters
that follow this overview, several groups with much
larger samples simply haven’t found the variant—at
all—in their collections of depressed subjects, unipolar
or bipolar. And not even in their controls. My own group
also found an absence of the variant in our own depres-
sion cohort (H.C. Prasad, E. Sanders-Bush, R.C. Shel-
ton, and R.D.B., unpublished data). In such circumstan-
ces, the possibility of an experimenter mistake looms
large among possible explanations. However, by shar-
ing their DNAs with several of the groups attempting
replication, Caron and workers put this concern to
rest. It is possible that replicates can fail simply because
the sample sizes are too small. Here, however, we see
nearly 5000 subjects sampled from multiple ethnic
groups in the replicate attempts, making the findings
of Zhang et al., as one correspondent infers, ‘‘a million
to one shot.’’ Given that the results have been validated
by other groups using the Zhang et al. samples (a good
practice for those of us analyzing rare mutations), the
findings point to something quite distinct and possibly
very important apart from depression per se in the sub-
jects studied by Zhang et al. that enriches for the TPH2
Arg441His variant. The subjects studied by Zhang et al.
are elderly, and many are severely depressed. Rare al-
leles in a number of genes, several now known to pres-
ent with functional phenotypes (Halushka et al., 1999;
Hahn et al. 2005), have been isolated by using blood
pressure extremes to cull out contributors to hyper/
hypotension. Perhaps the extremes of the depression
spectrum have been sampled by Zhang et al., although
this raises the question of how they could find it in theircontrol samples (yet others do not see this either). A rea-
sonable person could claim, today, that these variants
track with something having nothing to do with depres-
sion, just a shared characteristic yet to be recognized
and controlled for. While I doubt that this is likely to be
the case, I admit that my view is only a hunch. The iden-
tification of multiple homozygotes carrying alleles that
no one can find in single copy seems too low a probabil-
ity not to point to a key depression trait enriched in the
Zhang et al. samples. Clearly, we need to know more
about the subjects of Zhang et al. Of course, having ac-
cess to their brain serotonin levels would be helpful,
though possibly CSF serotonin metabolites may be all
that we can reasonably expect.
In their response to the correspondents below,
Caron and colleagues suggest a key trait linked to the
Arg441His substitution may be severe depression that
is refractory to conventional medications, necessitating
ECT. Presumably what led to the initial findings was
a shared trait linked both to serotonin and depression,
but not depression itself. It would be ideal to track these
traits, or endophenotypes, within the families of the
Zhang et al., cohort, though the elderly nature of the co-
hort leaves open the possibility that these traits emerge
only late in life, a depressing thought considering the
finite lifetime of the funding that sustains such studies.
In time, the sampling of additional collections bearing
greater similarity to that of Zhang et al. in search of
Arg441His may clarify the issue. Until then, we must con-
clude that this TPH2 allele (as well as any other TPH2
coding variant, based on resequencing efforts de-
scribed below) is not a major determinant of genetic
risk for major depression. Other alleles, for example in
the TPH2 promoter, may still be worth exploring, as ev-
idence suggests that some form of variation at or near
the TPH2 locus associates more broadly with major de-
pression (Zill et al., 2004). The rarity of the Arg441His
mutation doesn’t mean that it is a less valuable find-
ing—it may be a single nugget that points to a rich
vein that we can mine for other gold. Recall just how
few people have a synuclein or presenillin mutations,
relative to the numbers stricken with Parkinson’s and
Alzheimer’s disease, respectively. Yet the study of the
pathways influenced by these genes are now seen as
being central to efforts to treat and one day eradicate
these disorders.
Under a common disease/rare variant framework,
there may simply be no single gene variant imposing
a major effect on population risk for depression. Given
that more than 100 genes are likely to be involved in
the birth, development, function, and plasticity of sero-
tonergic neurons (there are more than a dozen serotonin
receptors, and the serotonin transporter alone is now
known to associate with more than half a dozen pro-
teins), even a serotonin centrist should expect contribu-
tions from many points in the network for something as
complex an endpoint as depression. Regardless, a flag
has been planted, land claimed for the amine, land
that was only suspected to be out there before. It is
something of a brave new world for sure, and some
be more abundant in a cohort of 87 depressed patients
compared to 219 controls (Zhang et al., 2005). The fre-
quency of His441 was higher in the depressed patients
(0.06), among whom there were two His/His homozy-
gotes and seven heterozygotes. His441 was also ob-
served among the 219 controls (allele frequency
0.009), among whom one His/His homozygote and two
Arg/His heterozygotes were detected. This reported as-
sociation with depression is of note in the context of the
effect of this substitution in reducing serotonin synthe-
sis by approximately 80% in a heterologous expression
assay in a rat cell line (Zhang et al., 2005) and through the
observation of the role of TPH2 variants as genetic pre-
dictors of depression (Zill et al., 2004) and response to
antidepressants (Peters et al., 2004).
The authors of this letter represent three independent
groups of investigators who have resequenced the rele-
vant region of TPH2 in some 779 unrelated individuals
(Table 1), including 403 with major depression (ages
19–74, n = 21 > 60 years). In addition, another 1740 indi-
viduals with major depression (from the STAR*D study,
ages 18–75, n = 121 > 60 years) were genotyped (Table
1). The sequenced and genotyped individuals represent
five ethnic populations. Psychiatric assessment was
accomplished using semistructured psychiatric inter-
views: NIAAA, SCID or SADS-L; NIMH and UCSF,
SCID-I/P. Major depression was diagnosed by DSM-
III-R or DSM-IV criteria, and a DSM-IV checklist was
used for the STAR*D samples. Additional descriptions
of individual data sets have been reported (Nielsen
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702yet do not believe it truly exists. What manner of discov-
ery Arg441His truly is, only time will tell. I, for one, would
gamble on treasures beyond the beachhead. But it may
be a treasure of small gems, one that must be
appreciated in the context of other jewels, mined else-
where and assembled patiently over time, to be
a crowning achievement.
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Zhang et al. reported a naturally occurring Arg441His
missense variant of the human tryptophan hydroxy-
lase-2 (TPH2) gene. The His441 allele was reported to
et al., 1998; Robin et al., 1997; Roy, 2003; Peters
et al., 2004; Rush et al., 2004). All data were collected
following informed consent and under human research
protocols approved by IRBs of the respective institu-
tions. For direct sequencing, genomic DNA was ampli-
fied by PCR with primers encompassing the Arg441His
variant, sequenced using the BigDye Terminator V3.1
(Applied Biosystems Inc., Foster City, CA) and analyzed
on ABI 3100 or 3730 sequencers. For genotyping, as-
says were performed using 50-nuclease assay (TaqMan,
ID # PMT06-55) and analyzed on an LJL plate reader
(Molecular Devices, Sunnyvale, CA). 20% of the
Table 1. Individuals Sequenced or Genotyped for TPH2 Arg441His
Direct Sequencing
Genotyping
NIAAA UCSF NIMH Total NIMH
Major depression 295 108 403 1740
Caucasian 124 83 207 1411
African American 63 8 71 213
American Indian 101 0 101 0
Hispanic 0 11 11 0
Asian-American 2 6 8 0
Others 5 0 5 116
Control 152 200 352
Caucasian 87 100 187
African American 63 100 163
American Indian 2 0 2
Bipolar 24 24
Caucasian 24 24
African American
American Indian
Total 447 308 24 779 1740
Grand total 2519
